Immunology and Microbiology
Prevalence
100%
Severe Acute Respiratory Syndrome Coronavirus 2
70%
Escherichia coli
59%
Colistin
56%
Human Immunodeficiency Virus 1
42%
Genomic Surveillance
42%
Antimicrobial Resistance
35%
COVID-19
33%
Gram-Negative Bacteria
30%
Intestine Parasite
30%
Human Immunodeficiency Virus
29%
Hepatitis B Virus
26%
Infectious Agent
24%
Parasitemia
24%
Cladistics
22%
Dynamics
22%
Viral Load
21%
Blood Plasma
21%
Drug Resistance
19%
Omicron Coronavirus Variant
18%
Bacterial Growth
16%
Coinfection
16%
CD4
16%
Genetic Variability
15%
Parasitic Disease
14%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
60%
Prevalence
55%
Escherichia coli
47%
SARS Coronavirus
42%
Retrospective Study
42%
Diseases
41%
Seroprevalence
28%
Colistimethate
28%
Antimicrobial Resistance
26%
Antibiotics
26%
Human Papillomavirus
23%
Mixed Infection
17%
Parasitemia
17%
Cross Sectional Study
16%
Infectious Agent
16%
Antiinfective Agent
15%
Cross-Sectional Study
15%
Helminth
14%
Praziquantel
14%
Extended Spectrum Beta Lactamase
14%
Penicillinase
14%
Carbapenemase
14%
Intestine Parasite
14%
Diclofenac
14%
Severe Acute Respiratory Syndrome
14%
Medicine and Dentistry
Prevalence
69%
Severe Acute Respiratory Syndrome Coronavirus 2
56%
Parasitic Disease
40%
COVID-19
35%
Pathogen
33%
Intestinal Parasite
30%
Low and Middle Income Countries
30%
Parasitic Disease
28%
Diclofenac
28%
Retrospective Study
28%
Diseases
25%
Public Health
21%
Infectious Disease
20%
Wart Virus
18%
Infection
17%
Systematic Review
15%
Case Finding
14%
Meta-Analysis
14%
Human Respiratory Syncytial Virus
14%
Human Immunodeficiency Virus
14%
Influenza A
14%
Colposcopy
14%
Precancerous Condition
14%
Psychiatry
14%
Non Communicable Disease
14%
